SCHEMBL4267916

SCHEMBL4267916

O=C(O)C(Cc1cccc(F)c1)NCS(=O)(=O)C1(c2c(Cc3ccccc3)oc3ccccc23)C=CC(c2ccccc2)C=C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 3/20 0.37
MME P08473 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
PTPN1 P18031 7/20 0.35
ADAMTS4 O75173 1/20 0.35
MMP2 P08253 1/20 0.35
MMP13 P45452 1/20 0.35
MMP14 P50281 1/20 0.35
ALB P02768 1/20 0.34
IL2 P60568 1/20 0.34
PTPRF P10586 1/20 0.33
PTPRA P18433 1/20 0.33
PTPN7 P35236 1/20 0.33
DUSP3 P51452 1/20 0.33
MTNR1A P48039 2/20 0.32
MTNR1B P49286 2/20 0.32
ALDH1A1 P00352 1/20 0.32
SLC1A1 P43005 2/20 0.32
PPARG P37231 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4260725 0.93 ALDH1A1 (0.39) ECE1MMEMEN1KMT2APTPN1
SCHEMBL4275265 0.83 MMP2 (0.37) ECE1MMEMEN1KMT2APTPN1
SCHEMBL5743846 0.78 TAS2R14 (0.36) MEN1KMT2APTPN1MTNR1AMTNR1B
SCHEMBL4261637 0.75 PTPN1 (0.38) PTPN1ADAMTS4MMP2MMP13MMP14
SCHEMBL4267879 0.74 PTPN1 (0.34) PTPN1ADAMTS4MMP2MMP13MMP14
SCHEMBL6729710 0.73 PTPN1 (0.50) PTPN1PTPRFPTPRAPTPN7DUSP3
SCHEMBL4265268 0.72 MMP2 (0.39) ECE1MMEMEN1KMT2APTPN1
SCHEMBL4273033 0.71 MMP2 (0.56) PTPN1ADAMTS4MMP2MMP13MMP14
SCHEMBL4273027 0.71 MMP2 (0.56) PTPN1ADAMTS4MMP2MMP13MMP14
SCHEMBL5766957 0.70 PTPN1 (0.48) PTPN1PTPRFPTPRAPTPN7DUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090082392-A1 Substituted Carboxylic Acids THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY LLC 2009-03-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090082392-A1 Substituted Carboxylic Acids PTPRJ, PTPRS, PTPRG ECE1 1688/4885MME 3001/4885MEN1 3127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.